Cancer Family
Carcinoma
CI-CAN-00000114Explore in graph →
7,369 active trials118 approved drugs1,149 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000114Explore in graph →
Clinical trials
25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3,405)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097214 |
| Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) |
| completed |
| Phase 2 |
| 57 |
| Eli Lilly and CompanyINDUSTRY |
| 1 |
| Apr 9, 2010 |
| clinicaltrials |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 165 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00005804 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00700440 | Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy(ENCORE) | completed | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Mar 26, 2010 | clinicaltrials |
| NCT00099879 | Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer | terminated | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 7 | Mar 2, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00359450 | Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) | terminated | Phase 2 | 186 | Bristol-Myers SquibbINDUSTRY | 8 | Mar 2, 2010 | clinicaltrials |
| NCT00707681 | Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) | unknown | Phase 2 | 60 | Microbio Co LtdINDUSTRY | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00254540 | Study of SU011248 in Patients With Advanced Kidney Cancer | completed | Phase 2 | 51 | PfizerINDUSTRY | 1 | Feb 23, 2010 | clinicaltrials |
| NCT00277329 | Study of XL999 in Patients With Non-small Cell Lung Cancer | terminated | Phase 2 | 9 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 22, 2010 | clinicaltrials |
| NCT00277316 | Study of XL999 in Patients With Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 11 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 19, 2010 | clinicaltrials |
| NCT00247676 | An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer | completed | Phase 2 | 37 | PfizerINDUSTRY | 3 | Feb 18, 2010 | clinicaltrials |
| NCT01070537 | Evaluation of the Bonfils Fiberscope for Predicted Difficult Intubation in Awake Patients With Ear, Nose, and Throat (ENT) Cancer (INVIBO)(INVIBO) | completed | Phase 2 | 41 | Centre Leon BerardOTHER | 1 | Feb 18, 2010 | clinicaltrials |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 17, 2010 | clinicaltrials |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 133 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 17, 2010 | clinicaltrials |
| NCT00128999 | Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 5 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00862004 | Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT01054482 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00473486 | Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib(PECASO) | terminated | Phase 1 / Phase 2 | 12 | University Hospital MuensterOTHER | 1 | Jan 27, 2010 | clinicaltrials |
| NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | unknown | Phase 2 | 250 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00264134 | Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 40 | Kentuckiana Cancer InstituteOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT01051362 | Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 48 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00516100 | Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC | unknown | Phase 1 / Phase 2 | 62 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01048645 | Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00089648 | SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 61 | PfizerINDUSTRY | 1 | Jan 12, 2010 | clinicaltrials |
| NCT01041482 | A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma(AGuo) | unknown | Phase 2 | 140 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00997724 | Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer(VATS) | unknown | Phase 2 | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT01039181 | Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 28 | National Science and Technology Development Agency, ThailandOTHER_GOV | 1 | Dec 24, 2009 | clinicaltrials |
| NCT01037998 | UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer | completed | Phase 2 | 115 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00615758 | Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00684099 | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 70 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00140478 | Mifepristone (RU-486) in Androgen Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 226 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00271271 | Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients(GON) | completed | Phase 2 | 40 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00424853 | ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 88 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00425191 | Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. | completed | Phase 2 | 165 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00557596 | A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 48 | Aegera TherapeuticsINDUSTRY | 1 | Dec 1, 2009 | clinicaltrials |
| NCT01019798 | Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer | unknown | Phase 2 | 16 | Taipei Medical University HospitalOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00712621 | Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination | withdrawn | Phase 2 | 460 | American Scitech InternationalOTHER | 1 | Nov 24, 2009 | clinicaltrials |
| NCT00494026 | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) | terminated | Phase 2 | 4 | Eli Lilly and CompanyINDUSTRY | 4 | Nov 20, 2009 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | terminated | Phase 1 / Phase 2 | 9 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 28, 2009 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Apr 12, 2010source: clinicaltrials